OptimMRI
by Rebrain, Sas
510(k) K230150Ref v2
Active
Valid until
No date given
FDA recalls
None found
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| European Union | CE/MDR EUDAMED | Number3770021895OMRI14M 03770021895035 | Date8 Jul 2025 | StatusActive |
| United States | GUDID listing GUDID | Number03770021895035 | Date22 Oct 2024 | StatusListed |
| United States | FDA 510(k)SESE GUDID | NumberK242054 | Date12 Aug 2024 | StatusActive |
| United States | FDA 510(k)SESE 510(k) | NumberK230150 | Date21 Jul 2023 | StatusActive |
Official records
- EUDAMED public site 3770021895OMRI14M
- AccessGUDID record 03770021895035
- FDA 510(k) database K242054
- FDA 510(k) database K230150
Across registries
- EUDAMED Basic UDI-DI 3770021895OMRI14M registered 8 Jul 2025 Active
- FDA 510(k) K242054 decided 12 Aug 2024 Active
- FDA GUDID UDI-DI 03770021895035 listed 22 Oct 2024 Listed
Timeline
- Cleared FDA 510(k) K230150
- Cleared FDA 510(k) K242054
- Listed FDA GUDID 03770021895035
- Registered EUDAMED 3770021895OMRI14M
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
- European Union
- United States
Specification
- Trade name
- OptimMRI EUDAMEDOptimMRI (v2) GUDID
- Generic name
- Stereotactic system application software
- Model / reference
- v2 EUDAMEDv2.0.1 GUDID
- Primary DI / UDI-DI
- 03770021895035
- Basic UDI-DI
- 3770021895OMRI14M
- FDA product code
- QIH, LLZ
- EMDN code
- Z12100692 Stereotactic neurosurgery instruments - medical device software
- GMDN term
- Stereotactic system application software
- Device class
- Class IIa EUDAMEDClass II 510(k)GUDID
- Regulation
- 21 CFR Part 892.2050
- Special device type
- Software
- EU registration type
- Standard device
- EU market of registration
- Spain
- Advisory committee
- Radiology
- FDA decision
- SESE Substantially Equivalent
- GUDID distribution status
- In Commercial Distribution
Truth per registry
| Field | EUDAMED | 510(k) | GUDID |
|---|---|---|---|
| Model / reference | v2 | — | v2.0.1 |
| 510(k) Number | — | K230150 | K242054 |
| Device class | Class IIa | Class II | Class II |
Overview
AI-generated summary, 18 Sep 2026
OptimMRI is a magnetic resonance imaging (MRI) optimization device designed to enhance MRI scan quality and efficiency. It is classified under the product code QIH and falls within the Radiology advisory committee category, supporting diagnostic imaging workflows by refining signal processing and artifact reduction.
The device is supplied as a software-based solution, intended for use in MRI-compatible environments. It is intended for single-use or reusable configurations depending on the implementation, though no explicit sterility or reuse instructions are provided in the data. Authorized under FDA 510K clearance and MDR compliance, it operates within standard MRI safety guidelines without requiring special storage conditions.
Devices cleared under K230150
Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.
| UDI-DI | Size and differences | |||
|---|---|---|---|---|
| OptimMRI v1.2.0 | v1.2.0 | 03770021895011 | — | On the market |
Similar devices in this category
Other devices filed under STEREOTACTIC NEUROSURGERY INSTRUMENTS.
- NextAR Spine Platform 98.46.NEXTAR by Medacta International SA
- ClearPoint CP-SFW-11-30 by Clearpoint Neuro, Inc.
- 803361 by inomed Medizintechnik GmbH
- Leksell Stereotactic System 1040153 by Elekta Solutions AB
- neuromate planning station hardware neuroinspire PC - Desktop US 001.0119 by RENISHAW MAYFIELD
- Leksell Vantage Stereotactic System 1040019 1040033 by Elekta Solutions AB
- Nexframe DB-2040-00780 by FHC, INC.
- Medtronic 9733935 by Medtronic Navigation Inc.
- NextAR Spine Platform 03.57.10.0005 by Medacta International SA
- 803365 by inomed Medizintechnik GmbH